Thematic Area: 
Autosomal Dominant Polycystic Kidney Disease   

Expert Recommendations

KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Reference: Kidney Disease: Improving Global Outcomes (KDIGO) ADPKD Work Group. KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney Int. 2025;107(2S):S1–S239

 

KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary

Reference: Torres VE, Ahn C, Barten TRM, et al. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. Kidney Int. 2025;107(2):234-254. doi:10.1016/j.kint.2024.07.010

 

The KDIGO 2025 Clinical Practice Guideline (CPG) on ADPKD was reviewed and evaluated by ERKNet experts using the AGREE-II methodology. Following this assessment, the ERKNet Network Board officially endorsed the guideline and committed to implementing its recommendations in clinical practice.